VITALOGRAPH LIMITED
Get an alert when VITALOGRAPH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£7.9m
-18.5% lowest in 3 filed years
Net assets
£11m
+4.6% highest in 3 filed years
Employees
150
+6.4% highest in 3 filed years
Profit before tax
£627k
-83% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-10-20.
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £34,228,049 | £46,408,140 | £38,934,325 | -16.1% | |
| Operating profit | £2,608,472 | £3,141,403 | £207,314 | -93.4% | |
| Profit before tax | £3,151,262 | £3,686,920 | £627,355 | -83% | |
| Net profit | £2,439,354 | £2,782,427 | £472,313 | -83% | |
| Cash | £13,406,126 | £9,644,438 | £7,860,628 | -18.5% | |
| Total assets less current liabilities | £7,475,591 | £10,255,661 | £10,751,678 | +4.8% | |
| Net assets | £7,459,331 | £10,241,758 | £10,714,071 | +4.6% | |
| Equity | £7,459,331 | £10,241,758 | £10,714,071 | +4.6% | |
| Average employees | 111 | 141 | 150 | +6.4% | |
| Wages | £4,937,770 | £5,877,836 | £7,485,696 | +27.4% | |
| Directors' remuneration | £502,649 | £539,805 | £667,244 | +23.6% | |
| Directors' pension contributions | £27,606 | £28,435 | £35,897 | +26.2% | |
| Highest paid director | £145,349 | £163,903 | £224,389 | +36.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 7.6% | 6.8% | 0.5% | |
| Net margin | 7.1% | 6.0% | 1.2% | |
| Return on capital employed | 34.9% | 30.6% | 1.9% | |
| Gearing (liabilities / total assets) | 74.1% | 69.8% | 64.4% | |
| Current ratio | 1.33x | 1.42x | 1.52x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Auditor
- Brebners Chartered Accountants & Statutory Auditor
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- VITALOGRAPH LIMITED · parent
- Garthur (London) Limited 100%
Significant events
- “Vitalograph Limited continues to be a world leading provider of outstanding quality cardio-respiratory diagnostic devices, clinical trial services and medial equipment servicing.”
- “As previously reported, the board continues to invest heavily in the development of new products and services. The directors are pleased to report that this continued investment has resulted in continued profitability in the current financial year. Over the medium term, the directors expect to grow revenues faster than costs, whilst continuing to invest in research and development, and so increase profits.”
- “The principal activity and trading performance of the company is expected to remain consistent for the foreseeable future.”
- “The board has continued to invest heavily in the development of new products and services. The company continues to develop new products within diagnostic and therapeutic medical instrumentation for markets in the UK and internationally. The directors are pleased to report that this continued investment has resulted in continued profitability in the current financial year.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
8 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GARBE, John Marcus | Secretary | — | — | British |
| GARBE, Bernhardt Rudolph | Director | — | Aug 1953 | British |
| GARBE, John Marcus | Director | — | Mar 1958 | British |
| JAMES, Richard John | Director | 2020-12-16 | Aug 1974 | British |
| KEANE, Frank John | Director | 2016-01-01 | Feb 1965 | Irish |
| LANCASTER, Gary Neil | Director | 2025-12-17 | Mar 1967 | British |
| MOORE, Kevin John | Director | 2016-01-01 | Jul 1972 | Irish |
| VENN, Helen Elizabeth | Director | 2021-03-01 | Jan 1980 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BEMISTER, Robert Henry | Director | 2010-10-01 | 2020-05-11 |
| BURDEN, Norman | Director | — | 1993-10-06 |
| FLYNN, Francis George Arthur | Director | 1992-05-21 | 2004-12-10 |
| GARBE, Gudrun | Director | — | 2018-06-30 |
| GRIFFITHS, Raymond Edward | Director | 1992-05-21 | 1997-12-31 |
| HOWELLS, Thomas Hilary, Dr | Director | — | 2003-07-11 |
| LINDSAY, Michael John | Director | — | 2018-06-30 |
| MITCHELL, Peter | Director | — | 1992-12-31 |
| WEIDMAN, Lewis | Director | 2001-07-20 | 2018-06-30 |
| ZAGERMANN, Sascha | Director | 2013-01-01 | 2024-07-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Vitalograph (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 138 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-13 | AA | accounts | Accounts with accounts type full | |
| 2026-01-05 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-01 | CH01 | officers | Change person director company with change date | |
| 2025-10-01 | CH01 | officers | Change person director company with change date | |
| 2025-07-15 | AA | accounts | Accounts with accounts type full | |
| 2025-02-12 | CH01 | officers | Change person director company with change date | |
| 2025-02-12 | CH03 | officers | Change person secretary company with change date | |
| 2024-10-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-17 | AA | accounts | Accounts with accounts type full | |
| 2024-07-31 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-15 | AA | accounts | Accounts with accounts type full | |
| 2023-03-14 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-03-14 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-03-14 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-03-14 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-03-14 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-10-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-29 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.